Share Name Share Symbol Market Type Share ISIN Share Description
Oakley Capital Investments Limited LSE:OCI London Ordinary Share BMG670131058 ORD 1P (DI)
  Price Change % Change Share Price Shares Traded Last Trade
  -1.50 -0.58% 257.50 190,260 14:12:55
Bid Price Offer Price High Price Low Price Open Price
255.00 260.00 259.00 257.50 258.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 153.16 66.00 3.9 483
Last Trade Time Trade Type Trade Size Trade Price Currency
16:18:34 O 1,800 257.90 GBX

Oakley Capital Investments (OCI) Latest News

More Oakley Capital Investments News
Oakley Capital Investments Investors    Oakley Capital Investments Takeover Rumours

Oakley Capital Investments (OCI) Discussions and Chat

Oakley Capital Investments Forums and Chat

Date Time Title Posts
22/10/202008:09Oakley Capital Investments350

Add a New Thread

Oakley Capital Investments (OCI) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2020-12-01 16:18:35257.901,8004,642.20O
2020-12-01 15:42:56257.905001,289.50O
2020-12-01 15:39:40258.003,0007,740.00O
2020-12-01 15:30:32258.001,4073,630.06O
2020-12-01 14:48:53260.0011,50029,900.00O
View all Oakley Capital Investments trades in real-time

Oakley Capital Investments (OCI) Top Chat Posts

Oakley Capital Investments Daily Update: Oakley Capital Investments Limited is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker OCI. The last closing price for Oakley Capital Investments was 259p.
Oakley Capital Investments Limited has a 4 week average price of 251.50p and a 12 week average price of 243p.
The 1 year high share price is 285p while the 1 year low share price is currently 157.50p.
There are currently 187,546,936 shares in issue and the average daily traded volume is 101,815 shares. The market capitalisation of Oakley Capital Investments Limited is £482,933,360.20.
davebowler: Liberum; £43m investment in WindStar Medical via Fund IV Mkt Cap £480m | Prem/(disc) -27.6% | Div yield 1.8% Event Oakley Capital Investments has announced that Oakley Capital Fund IV has agreed to acquire WindStar Medical GmbH, Germany's leading over-the-counter consumer healthcare company. OCI's indirect contribution to the investment will be up to c.£43m, dependent on the capital structure at completion, and the transaction is expected to be completed by the end of the year. WindStar Medical's platform, which is expected to generate over €120m in revenues this year, designs, develops and commercialises branded consumer health and private label products, with a track record of establishing best-in-class medical formulations and brands. The consumer brands segment of the business offers a wide range of premium high-growth branded products in Germany, including SOS (wound care / disinfectants), Zirkulin (gastro-intestinal care), GreenDoc (mental wellbeing) and EyeMedica (eye health). It is also a provider of private label products to the leading German drug stores and supermarkets, whilst also developing an international distribution footprint through existing and new partners. Liberum view The investment in WindStar Medical builds on Oakley's successful track record of investing in leading consumer platforms in the DACH region. The business has many of the traits Oakley looks for when acquiring a business, being an asset-light model with industry-leading operational capabilities and an attractive growth profile. WindStar looks well placed to benefit from the structural growth within the German consumer healthcare market. Market data suggests that the sector is growing at 5-6% a year, driven both by demographic trends, such as an ageing population, and a shift in consumer preferences driven by factors such as increased awareness of physical and mental wellbeing and willingness to prevent illness. There is also an apparent shift away from the pharmacy and towards traditional retail outlets. This is driving greater growth in the market overall and also a shift to white label products. OCI is well placed to capitalise on further attractive investment opportunities with more than £200m of cash following recent acquisitions. The shares trade on a c.30% discount to our pro-forma NAV estimate, which we regard as highly attractive given the manager's track record and the NAV growth potential of the fund.
brexitplus: Just watched Martin Sorrell talking about where he would invest now. OCI covers most bases except healthcare.
1968jon: Of the £430m of NAV that isn't cash, £125m is debt. Ordinarily debt should be discounted less than equity.......? Just for fun apply a 5% haircut to the cash and debt and you get £367m or £1.89 per share. With a share price of £2.50 that implies a value of 61p per share for the equity or a discount to NAV of 63% I think...61p versus 167p rather than the 48% discount implied above by Simon Thompson 115p versus 221p. I did those numbers quickly so don't hold me to them.
value hound: Tipped again by Simon Thompson today. "There is no doubt in my mind that the shares remain priced for a profitable outcome. Adjust for cash and Oakley’s private equity portfolio (221p a share) is in the price for almost half of book value"
davebowler: Liberum; Event Oakley Capital Investments' NAV per share at 30 June 2020 was 356p (previously reported), representing a 3.8% NAV total return in H1 2020 and 13.3% over the past 12 months. OCI has generated an annualised NAV total return of 16.5% over the three years to June 2020, the highest of the listed private equity funds. NAV performance in H1 2020 benefited from realisations and resilient performance from the portfolio companies. This is due to the bias towards software, tech-enabled services, online platforms and subscription-based revenue models. The key drivers of NAV performance in the period included: Inspired (+2.9%) - 25% uplift to December 2019 book value following full realisation in April Career Partner Group (+3.4%) - Trading for the German university group has been very strong with a significant rise in the intake of online students. Paying students have increased by 59% y-o-y Time Out (-7.5%) - market closures and advertising declines due to Covid1-9 led to a 68% decline in the share price over the six months to 30 June FX (+4.5%) 12 of the 15 portfolio companies are expected to be at or near budget for the full year. Average annual EDITDA growth for the portfolio was 17.5% for the 12 months to June 2020. This compares to 30% over the 12 months to June 2019, with the decline largely a result of impacts from Covid-19. The portfolio is valued on an average 11.8x EV/EBITDA multiple (2019: 12.0x) and leverage is relatively low compared to peers at 3.7x net debt/EBITDA (2019: 4.1x). £291m of cash was generated for OCI in the period, predominantly as a result of large realisations in Inspired (£114m, 25% premium to book value) and WebPros (£116m, 152% IRR). Cash on the balance sheet of £261m at the period end represents 38% of NAV. Liberum view Most of the key numbers had been reported previously in the trading update and the comprehensive capital markets day. The results have illustrated the resilient trading performance of the portfolio with the majority expected to be at or close to budget for the full year. OCI has been the best-performing private equity fund over the last three years and we believe the fund is well positioned to maintain its outperformance. We note most of the better performing portfolio companies are still held at cost, offering the potential for further NAV upside. Oakley has a track record of completing accretive exits to large buyout funds. The majority of Oakley's investments have been sourced primarily from bilateral discussions with vendors, working directly with the founders, and Oakley usually does not acquire via secondary buyouts from other private equity houses. This has enabled Oakley to acquire businesses at very attractive valuations. The high cash balance leaves OCI in an excellent position to capitalise on a favourable environment for new investments. Fund IV is 30% deployed and OCI also recently committed to the Origin Fund (focusing on lower mid-market private companies). We believe the shares offer exceptional value given the quality of the portfolio and the manager's track record in creating value. We note the board and manager's strong alignment of interests and desire to improve the share rating, as demonstrated by consistent share buybacks (£16m acquired since March).
davebowler: Liberum; Note: Digital focus providing resilience Mkt Cap £454m | Prem/(disc) -33.1% | Div yield 1.9% Event OCI’s portfolio is focused on digital business models with recurring or subscription-based revenues. Recent accretive disposals have left the company’s balance sheet in excellent shape, with no leverage and a cash balance of £261.5m (38% of NAV). The share price implies a 53% discount on the portfolio value (ex-cash). We believe this is unjustified, especially given the positive NAV performance during the pandemic and Oakley’s track record of delivering NAV growth and achieving material uplifts on exits (average 34% uplift on realisations since inception).
apollocreed1: I wonder what percentage of OCI's assets are in Euros... Because if we get some kind of Brexit deal the pound will rise and cause an instant loss to OCI.
sharesoc: The Oakley presentation and Stockopedia report from our recent company webinar can be found in our members area here: hTTps:// To access the presentation, you'll need to be a full member of ShareSoc, which is a not-for-profit organisation that supports individual shareholders and campaigns for shareholder rights. If you're not already a member you can join here: hxxps:// Once you've joined, you'll receive an invitation to register for our "members network" private social network, from where you'll be able to access the presentation (and presentations on 100s of other meetings). If you're already a member and have any difficulty accessing the report, please do not hesitate to contact us here: hxxps://
spectoacc: Agreed, TMO were just getting it together. The huge debt load/ongoing losses always an issue, but were in sight of breaking through. Not sure OCI has much choice but to support, with c.51% combined, but if I was a TMO shareholder I wouldn't much like that 12%. Really no govnt coronavirus loan available? And how much money will OCI need to throw at them? But enough from me - not tempted back to OCI just yet.
nimbo1: I hold oci, Apax and icg Specto - if oci price opens up less than 8percent I’ll buy more here too. bought more at 255 - cheaper than it was yesterday on a relative basis but price may have moved up in expectation over last 2 weeks
Oakley Capital Investments share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Oakley Cap..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201202 00:59:20